Rep. Byron Donalds bought Brown & Brown (BRO)
Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Mar 20, 2025
Why this is a committee overlap
Donalds is a member of the House Committee on Financial Services, which oversees the Financial Services sector. Brown & Brown is classified in the Insurance - Brokers industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Mar 20, 2025
- Disclosed
- Apr 15, 2025
- Days to disclose
- 26
- Asset type
- Stock
- As filed
- Brown & Brown, Inc. Common Stock
- Industry
- Insurance - Brokers · Financial Services
Other trades in this filing
All of Donalds's trades →- Apr 15, 2025$1K–$15K
Sold (full) Veeva Systems VEEV
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Sold (full) JPMorgan Chase & JPM
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Bought Abbott Laboratories ABT
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Robinhood Markets HOOD
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Bought Chipotle Mexican Grill CMG
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) JPMorgan Chase & JPM
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Recent Congress trades in BRO
- Sep 10, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 10, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jun 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded May 1, 2026 · disclosed Jun 11, 2026 · Dependent
- May 7, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Brown & Brown BRO
$1K–$15K · Traded Apr 17, 2026 · disclosed May 7, 2026 · Dependent
- May 1, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed May 1, 2026 · Dependent
- May 1, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed May 1, 2026
- Mar 11, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Brown & Brown BRO
$1K–$15K · Traded Feb 24, 2026 · disclosed Mar 11, 2026 · Dependent
- Mar 11, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Feb 6, 2026 · disclosed Mar 11, 2026 · Dependent
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.